Pay in 4 interest-free payments of $6.78 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
PubMed , Journal of Physiology, Paris , vol
BPC-157, TB-500, and GHK-Cu reduce inflammatory cytokines while promoting anabolic tissue remodeling, which is the opposite of corticosteroid effects
See our BPC-157 & TB-500 recovery guide and TB-500 dosage guide
Read more Clinical & Technical Insights
In a randomized placebo-controlled phase IIA trial of patients with prior OHE, VE303 was well tolerated and showed a trend toward improved PHES [152]
In two Phase 2 clinical trials covering stasis and pressure ulcers, TB4 accelerated complete wound closure by almost a month in patients who achieved full healing representing one of the most substantial healing acceleration outcomes observed for a peptide compound in a controlled clinical investigation
US$ 28.34
US$ 24.66
US$ 22.69
US$ 21.96
US$ 27.29
US$ 24.02
US$ 25.38
US$ 23.21
US$ 23.99
US$ 22.08
